Since 1996, Headway has provided dependable diagnostic tools for identifying Helicobacter pylori infections. Their focus on precision and safety has made the Headway test a preferred choice in healthcare settings. Designed to be non-invasive and user-friendly, their breath test kits and analyzers support accurate detection across different patient groups, including children and pregnant women.
What Makes the Headway UBT Different
The Headway UBT (Urea Breath Test) offers a simple and effective way to screen for H. pylori by detecting urease activity in the stomach. Patients ingest a urea solution labeled with either carbon-13 or carbon-14, depending on the test type. The breakdown of this compound by H. pylori releases labeled carbon dioxide, which is then measured in the patient’s breath.
Headway offers two distinct types of UBT solutions. The Carbon13 Urea Breath Test Kit comes with the HCBT-01 UBT detector, a non-radioactive option ideal for widespread use. On the other hand, the Carbon14 Urea Capsule Breath Test Kit pairs with the HUBT-20P analyzer and provides fast, accurate, and highly sensitive results.
Headway Test Kits for All-Age Accessibility
The Headway test is well-regarded for its ease of use and safety. Because the procedures are painless and do not involve invasive tools, they are appropriate for use across a wide demographic. The ¹³C breath test is especially beneficial in settings where non-radioactive testing is preferred. Meanwhile, the ¹⁴C version ensures efficient diagnostics with its sensitive analyzer system.
Both systems are engineered to streamline the detection process, making them practical for hospitals, clinics, and laboratories that value speed and accuracy.
Conclusion
The Headway UBT is a reliable solution for healthcare providers looking to perform efficient H. pylori screening. With options that cater to various diagnostic needs, Headway test kits and analyzers provide a consistent method for detecting infection with minimal discomfort. Their long-standing commitment to safety and accuracy continues to support effective patient care worldwide.
